… safety of vildagliptin vs. glimepiride as add-on therapy to metformin in patients with type 2
diabetes mellitus in … The primary objective was to demonstrate non-inferiority of vildagliptin vs. …

… This study assessed the efficacy and safety of vildagliptin as add-on therapy to metformin
plus glimepiride combination in patients with type 2 diabetes mellitus (T2DM) who had …

… was to evaluate the efficacy and safety of vildagliptin, a potent dipeptidyl peptidase-4
inhibitor, as an add-on to metformin in Japanese patients with type 2 diabetes mellitus (T2DM). …

… This study showed the long-term efficacy and safety of vildagliptin as add-on therapy to
insulin in patients with T2DM. Treatment with vildagliptin maintained a reduction in HbA1c levels …

… treatment of type 2 diabetes with vildagliptin in Germany, we … 2 diabetic patients treated with
vildagliptin” (PROVIL). The aim of this study was to investigate the therapeutic efficacy, safety …

… –risk profile of vildagliptin has been generated in patients with type 2 diabetes mellitus (T2DM).
In this article, we review the cumulative evidence on the safety of vildagliptin from the …

… safety of combination therapy with vildagliptin and metformin vs. metformin monotherapy in
the treatment of type 2 diabetes mellitus (… combination therapy with vildagliptin and metformin …

… review of the safety and efficacy of vildagliptin in patients with type 2 diabetes. Clinical …
The addition of vildagliptin to metformin improves glucose control and significantly reduces …

… This systematic review and meta-analysis provides an update on the efficacy and safety
of vildagliptin for treatment of type 2 diabetes mellitus (T2DM). We searched MEDLINE, …

… diabetes mellitus, vildagliptin 50mg twice daily is indicated for use in combination with metformin
or a thiazolidinedione, and vildagliptin … of vildagliptin in patients with type 2 diabetes, as …